{"entity":{"id":"causaly","kind":"company","name":"Causaly","aka":[],"tldr":"Causaly provides software for searching biomedical evidence and exploring potential drug targets, including in prostate cancer.","summary":"Causaly develops a biomedical evidence platform with a knowledge graph and scientific research tools. Its official resources include a prostate cancer target-discovery factsheet. This supports inclusion as a cancer research tool provider, not as a cancer diagnostic service or a developer of a proven treatment. The company identifies London as its headquarters.","asOf":"2026-11-06","links":[{"label":"Prostate cancer target-discovery resource","url":"https://www.causaly.com/resources/downloads"},{"label":"Official location evidence","url":"https://www.causaly.com/about"},{"label":"Elicit AI for Pharma market map","url":"https://elicit.com/ai-for-pharma"}],"tags":[],"related":[],"cancers":[],"sections":["drug-discovery","ai-computation"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["No treatment effectiveness claim is inferred from a target-discovery resource."],"hq":"London","country":"GB","companyType":"ai-software","website":"https://www.causaly.com/","investors":[],"funding":[]},"route":"/companies/causaly/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"collection":[{"id":"elicit-ai-for-pharma","kind":"collection","name":"Elicit AI for Pharma market map","route":"/collections/elicit-ai-for-pharma/"}]}}